<DOC>
	<DOCNO>NCT01151865</DOCNO>
	<brief_summary>The primary aim DahLIA trial determine , patient ICU-associated delirium agitation otherwise pathophysiologically stable ( define ) , number ventilator-free hour incident ICU admission 7 day follow commencement trial medication , patient randomise receive dexmedetomidine placebo receive aspect standard care . The null hypothesis assume difference median number ventilator-free hour ICU admission follow 7 day , patient receive dexmedetomidine placebo ICU-associated agitation delirium .</brief_summary>
	<brief_title>Dexmedetomidine Lessen Intensive Care Unit ( ICU ) Agitation</brief_title>
	<detailed_description />
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Patients eligible study , opinion treat clinician , continue require mechanical ventilation degree agitation require high dose sedative medication ( midazolam propofol , commonly use specific sedative unit ) extubation possible , AND opinion treat intensivist agitation severe make lessening sedation unsafe . These criterion objectively quantify follow : require either mechanical restraint and/or antidelirium sedative medication 4 hour prior seek consent AND Confusion Assessment Method ICU ( CAMICU ) test positive delirium 4 hour prior seek consent AND Motor Activity Assessment Scale ( MAAS ) score 5 4 hour prior seek consent , confirm psychomotor agitation AND SOFA score less equal 5 4 hour prior seek consent , predict mortality around 5 % . Age le 18 year old Pregnancy breastfeeding Advanced dementia ( premorbid state require professional nursing care ) Open close head injury Death deem imminent inevitable The patient previously enrol DahLIA study Patients could extubated , would intubate within follow 48 hour , even delirium agitation correct . This include : Patients receive high dose opioid analgesia ( sedation ) ( &gt; 40 mg/morphine/day ) Patients shortly return operate theatre Patients undergo repeat invasive procedure , desirable maintain deep sedation Patients likely require ongoing airway protection control , ventilatory support ( example , spinal patient inadequate vital capacity ) Known allergy haloperidol alpha 2 agonist</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Delirium</keyword>
	<keyword>Intensive Care Unit</keyword>
	<keyword>Dexmedetomidine</keyword>
</DOC>